Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan A Grupp

Showing results (81-90 of 238) with videos related to

Pageof 24
Sort By:
Cancer Immunology, Immunotherapy : CII|June 20, 2014
Engineered T cells for cancer therapyCarl H June, Marcela V Maus, Gabriela Plesa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival updateRani E George, Shuli Li, Cheryl Medeiros-Nancarrow, et al.
Blood|October 1, 2005
The mTOR inhibitor CCI-779 induces apoptosis and inhibits growth in preclinical models of primary adult human ALLDavid T Teachey, Dana A Obzut, Jonathan Cooperman, et al.
Blood|August 23, 2011
Noninvasive bioluminescent imaging of primary patient acute lymphoblastic leukemia: a strategy for preclinical modelingDavid M Barrett, Alix E Seif, Carmine Carpenito, et al.
American Journal of Hematology|October 26, 2016
Repeated loss of target surface antigen after immunotherapy in primary mediastinal large B cell lymphomaHui Yu, Elena Sotillo, Colleen Harrington, et al.
Transplantation and Cellular Therapy|April 8, 2024
INSPIRED Symposium Part 5: Expanding the Use of CAR T Cells in Children and Young AdultsAimee C Talleur, Vanessa A Fabrizio, Richard Aplenc, et al.
American Journal of Hematology|September 18, 2023
Bone marrow fibrosis is associated with non-response to CD19 CAR T-cell therapy in B-acute lymphoblastic leukemiaJoshua Anil, Ahab Alnemri, Andrew Lytle, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 13, 2018
CD3<sup>+</sup>/CD19<sup>+</sup> Depleted Matched and Mismatched Unrelated Donor Hematopoietic Stem Cell Transplant with Targeted T Cell Addback Is Associated with Excellent Outcomes in Pediatric Patients with Nonmalignant Hematologic DisordersJoseph H Oved, Yongping Wang, David M Barrett, et al.
Oncoimmunology|March 5, 2016
T cells targeting NY-ESO-1 demonstrate efficacy against disseminated neuroblastomaNathan Singh, Irina Kulikovskaya, David M Barrett, et al.
Cancer Immunology Research|November 29, 2017
High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma ModelSarah A Richman, Selene Nunez-Cruz, Babak Moghimi, et al.
Pageof 24

Showing results (81-90 of 238) with videos related to

Sort By:
Pageof 24
Cancer Immunology, Immunotherapy : CII|June 20, 2014
Engineered T cells for cancer therapyCarl H June, Marcela V Maus, Gabriela Plesa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival updateRani E George, Shuli Li, Cheryl Medeiros-Nancarrow, et al.
Blood|October 1, 2005
The mTOR inhibitor CCI-779 induces apoptosis and inhibits growth in preclinical models of primary adult human ALLDavid T Teachey, Dana A Obzut, Jonathan Cooperman, et al.
Blood|August 23, 2011
Noninvasive bioluminescent imaging of primary patient acute lymphoblastic leukemia: a strategy for preclinical modelingDavid M Barrett, Alix E Seif, Carmine Carpenito, et al.
American Journal of Hematology|October 26, 2016
Repeated loss of target surface antigen after immunotherapy in primary mediastinal large B cell lymphomaHui Yu, Elena Sotillo, Colleen Harrington, et al.
Transplantation and Cellular Therapy|April 8, 2024
INSPIRED Symposium Part 5: Expanding the Use of CAR T Cells in Children and Young AdultsAimee C Talleur, Vanessa A Fabrizio, Richard Aplenc, et al.
American Journal of Hematology|September 18, 2023
Bone marrow fibrosis is associated with non-response to CD19 CAR T-cell therapy in B-acute lymphoblastic leukemiaJoshua Anil, Ahab Alnemri, Andrew Lytle, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 13, 2018
CD3<sup>+</sup>/CD19<sup>+</sup> Depleted Matched and Mismatched Unrelated Donor Hematopoietic Stem Cell Transplant with Targeted T Cell Addback Is Associated with Excellent Outcomes in Pediatric Patients with Nonmalignant Hematologic DisordersJoseph H Oved, Yongping Wang, David M Barrett, et al.
Oncoimmunology|March 5, 2016
T cells targeting NY-ESO-1 demonstrate efficacy against disseminated neuroblastomaNathan Singh, Irina Kulikovskaya, David M Barrett, et al.
Cancer Immunology Research|November 29, 2017
High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma ModelSarah A Richman, Selene Nunez-Cruz, Babak Moghimi, et al.
Pageof 24